Article

Lab21 and ITOR Unveil Major Leap Forward in Personalized Cancer Medicine

The new Lab21 Clinical Genomics Center at ITOR will allow cancer patients to benefit from new technology to receive real-time feedback and treatment plans tied to their cancer's specific DNA signature. Greenville Hospital System University Medical Center will be one of the first sites in the country to bring Ion Torrent next-generation gene-sequencing technology into a clinical environment for personalized oncology medicine studies.

Joe Stephenson

"Bringing this leading-edge technology to the cancer clinic represents a significant breakthrough and the culmination of a seven-year journey," said Dr. , medical director for GHS' Institute for Translational Oncology Research. "This genomics center is another major step towards fulfilling our vision to provide personalized cancer care — better enabling us to offer the right drug, at the right time, to the right patient."

Read the full story: http://hcp.lv/AlKgxQ

Source: bizjournals.com/PR Newswire

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
1 expert is featured in this series.
Miriam Freimer, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo